Antidote Therapeutics Progresses Optimization of the Nicotine-degrading Enzyme, NicA2, for Potential Use in Treating Nicotine Addiction
A new study, now published in BMC Biotechnology, demonstrates successful protein engineering resulting in a longer-acting enzyme, increased catalytic activity…